Gonzalez-Roca E, Garcia-Albeniz X, Rodriguez-Mulero S, Gomis RR, Kornacker K, Auer H. Accurate expression profiling of very small cell populations. PLoS One. 2010 Dec 28;5(12):e14418. doi: 10.1371/journal.pone.0014418
Talbird SE, Mauskopf J, Smets E, Brogan AJ. US cost effectiveness of darunavir/ritonavir 600/100 mg bid in treatment-experienced, HIV-infected adults with evidence of protease inhibitor resistance included in the TITAN Trial. Pharmacoeconomics. 2010 Dec 23;28(Suppl 1):129-46.
Fehnel SE, Manjunath R, Ervin CM, French JA, Vanlandingham K, Sweeney CT. Developing a functional status diary for epilepsy. Poster presented at the 64th Annual Meeting of the American Epilepsy Society; December 1, 2010.
McKenna SP, Doward LC, Twiss J, Hagell P, Oprandi NC, Fisk J, Grand'Maison F, Bhan V, Arbizu T, Brassat D, Kohlmann T, Meads DM, Eckert BJ. International development of the Patient-Reported Outcome Indices for Multiple Sclerosis (PRIMUS). Value Health. 2010 Dec 1;13(8):946-51.
Dalal AA, Demuro-Mercon C, Lewis S, Nelson L, Gilligan T, McLeod L. Validation of alternate modes of administration of the lung function questionnaire (LFQ) in subjects with smoking history. Int J Chron Obstruct Pulmon Dis. 2010 Dec 1;5:425-34.
Chung RT, Poordad FF, Hassanein T, Zhou X, Lentz E, Prabhakar A, Di Bisceglie AM. Association of host pharmacodynamic effects with virologic response to pegylated interferon alfa-2a/ribavirin in chronic hepatitis C. Hepatology. 2010 Dec 1;52(6):1906-14. doi: 10.1002/hep.23947
Meyers J, Classi P, Wietecha L, Candrilli S. Economic burden and comorbidities of attention-deficit/hyperactivity disorder among pediatric patients hospitalized in the United States. Child Adolesc Psychiatry Ment Health. 2010 Dec 1;4:31.
Vinceti M, Bonvicini F, Rothman KJ, Vescovi L, Wang FY. The relation between amyotrophic lateral sclerosis and inorganic selenium in drinking water: a population-based case-control study. Environ Health. 2010 Dec 1;9(Art. No. 77).
Fleming AD, Goatman KA, Philip S, Prescott GJ, Sharp PF, Olson JA. Automated grading for diabetic retinopathy: a large-scale audit using arbitration by clinical experts. Br J Ophthalmol. 2010 Dec 1;94(12):1606-10. doi: 10.1136/bjo.2009.176784
Lang K, Meyers JL, Korn JR, Lee S, Sikirica M, Crivera C, Dirani R, Menzin J. Medication adherence and hospitalization among patients with schizophrenia treated with antipsychotics. Psychiatr Serv. 2010 Dec 1;61(12):1239-47.
Ribeiro-Oliveira Jr A, Mol SS, Twiss J, Alencar GA, Miranda PA, Naves LA, Azevedo MF, Basilio FM, Boguszewski CL, Nogueira KC, Vilar L, Koltowska-Haggstrom M, McKenna SP. The brazilian version of the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA): four-stage translation and validation. Arq Bras Endocrinol Metabol. 2010 Dec;54(9):833-41.
Launois R, Le Moine JG, Huynh MT, Boissier MC. Efficacité et tolérance des traitements de la polyarthrite rhumatoïde étudiés par méta-analyse hiérarchique bayésienne: combinaison simultanée des résultats relevés dans les essais randomisés et les études observationnelles avec groupe controle. Presented at the French Society of Rheumatology 23rd Annual Congress; November 28, 2010. Paris, France.
Talbird SE, Taylor TN, Caporale J, Ismaila AS, Gomez J. Residual economic burden of Streptococcus pneumoniae- and nontypeable Haemophilus influenzae- associated disease following vaccination with PCV-7: a multicountry analysis. Vaccine. 2010 Nov 19;28(Suppl 6):G14-22.
Talbird SE, Taylor TN, Knoll S, Frostad CR, Marti SG. Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countries. Vaccine. 2010 Nov 19;28(Suppl 6):G23-9.
Talbird SE, Ismaila AS, Taylor TN. A steady-state, population-based model to estimate the direct and indirect effects of pneumococcal vaccines. Vaccine. 2010 Nov 19;28(Suppl 6):G3-G13.
Standaert B, Demarteau N, Talbird S, Mauskopf J. Modelling the effect of conjugate vaccines in pneumococcal disease: cohort or population models? Vaccine. 2010 Nov 19;28(Suppl 6):G30-8.
Williams VSL, Carson RT, Nelson LM, MacDougall J, Fehnel SE, Lewis B, Johnston JM. Application of exploratory factor analysis to support the conceptual framework of PRO measures: results from a phase 2 study of irritable bowel syndrome with constipation. Poster presented at the International Society for Quality of Life Research (ISOQOL) 2010 Annual Meeting; November 18, 2010.
Norquist JM, Girman CJ, Fehnel S, DeMuro C, Santanello N. Choice of recall period for patient-reported outcome measures: criteria for consideration. Poster presented at the International Society for Quality of Life Research (ISOQOL) 2010 Annual Meeting; November 18, 2010.
Harris DH. Six degrees of separation no more: using data linkages to improve the quality of cancer registry and study data. Poster presented at the American Public Health Association Annual Meeting & Exposition; November 6, 2010. Denver, CO.
Arana A, Ayuso-Mateos JL, Arellano FM. Suicide-related events in patients treated with antiepileptic drugs. Authors reply. N Engl J Med. 2010 Nov 4;363(19):1873-4.
Dickey H, Watson V, Zangelidis A. Is it all about money? An examination of the motives behind moonlighting. Appl Econ. 2010 Nov 3;43(26):3767-74. doi: 10.1080/00036841003724403
Valdivieso E, Rey C, Barrera M, Arija V, Basora J, Marsal JR, TAB_ES Study Group. Factors associated with commencing smoking in 12-year-old students in Catalonia (Spain): a cross-sectional population-based study. BMC Public Health. 2010 Nov 2;10:665. doi: 10.1186/1471-2458-10-665
Abu-Assi E, Ferreira-Gonzalez I, Ribera A, Marsal JR, Cascant P, Heras M, Bueno H, Sanchez PL, Aros F, Marrugat J, Garcia-Dorado D, Pena-Gil C, Gonzalez-Juanatey JR, Permanyer-Miralda G. Do GRACE (Global Registry of Acute Coronary events) risk scores still maintain their performance for predicting mortality in the era of contemporary management of acute coronary syndromes? Am Heart J. 2010 Nov;160(5):826-34. doi: 10.1016/j.ahj.2010.06.053
Twiss J, McKenna S, Doward LC, Hana V, Karbownik-Lewinksa M, Popovic V. Further developments of the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QOL-AGHDA). Poster presented at the 13th Annual European Congress; November 2010. Prague, Czech Republic. [abstract] Value Health. 2010 Nov; 13(7):A297.
Twiss J, McKenna S, Crawford SR, Doward LC. Scaling properties of two commonly used outcome measures in dermatology – the Dermatology Life Quality Index (DLQI) and the Psoriasis Quality of Life Scale (PSORIQoL). Presented at the 13th Annual European Congress; November 2010. Prague, Czech Republic. [abstract] Value Health. 2010 Nov; 13(7):A244.
Candrilli SD, O'Brien SH, Balkrishnan R. Economic outcomes associated with hydroxyurea adherence among pediatric Medicaid enrollees with sickle cell disease. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. [abstract] Value Health. 2010 Nov; 13(7):A463.
DeMuro-Mercon CJ, DiBenedetti DB, Lewis SA, Fehnel SE. Successful implementation of the cognitive interviews in special populations. Presented at the 17th Annual Conference of the International Society for Quality of Life Research; November 1, 2010. Previously presented at the 16th Annual Conference of the International Society for Quality of Life Research.
Johannes CB, Le TK, Zhou X, Johnston JA, Dworkin RH. The prevalence of chronic pain in United States adults: results of an internet-based survey. J Pain. 2010 Nov 1;11(11):1230-9.
Mladsi DM, Redekop K, Goettsch A, Earnshaw SR. Challenges and insights in establishing and communicating the economic value of companion diagnostics. Presented at the 2010 ISPOR 13th Annual European Congress; November 2010. Prague, Czech Republic.
Meyers J, Candrilli SD. Patient characteristics and charges associated with emergency department visits among patients with a diagnosis of restless legs syndrome. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. [abstract] Value Health. 2010 Nov; 13(7):A390.
Meyers J, Mitra D, Doan J, Leeflang C. The role of patient selection criteria in identifying ovarian cancer patients in a retrospective database analysis. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. [abstract] Value Health. 2010 Nov; 13(7):A281.
Karve S, Misurski D, Miller JM, Davis KL. Long-term economic and clinical burden of complicated invasive meningococcal disease: evidence from a United States managed care population. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. [abstract] Value Health. 2010 Nov; 13(7):A432.
Mladsi D. Review of utility estimates in atopic dermatitis. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. Prague, Czech Republic. [abstract] Value Health. 2010 Nov; 13(7):A402.
Mladsi D, Earnshaw S, Ronquest NA, Keith M. The threshold pricing model: not just another cost-effectiveness model. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. Prague, Czech Republic. [abstract] Value Health. 2010 Nov; 13(7):A332.
Mladsi D, Earnshaw S, Akashi-Ronquest N, Keith M. Proposed methods for conducting sensitivity analyses on threshold-derived estimates of value-based price and product profiles of early stage drugs. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. Prague, Czech Republic. [abstract] Value Health. 2010 Nov; 13(7):A333.
Lang K, Meyers JL, Kovacs B, Candrilli SD. Renal impairment in patients with type 2 diabetes mellitus and associated antihyperglycemic medication adjustment: evidence from an electronic medical records database. Poster presented at the 43rd Annual Meeting and Scientific Exposition of the American Society of Nephrology; November 2010.
Rycroft CE, Pearson IV, Khan S, Heyes AE. A tale of four countries: comparing reimbursement submission requirements in Ireland, England, Wales, and Scotland. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. [abstract] Value Health. 2010 Nov; 13(7):A418-9.
Coon CD, Price MA, Nelson LM. Advanced patient-reported outcomes assessment: psychometric methods. Presented at the 2010 ISPOR 13th Annual European Congress; November 2010. Prague, Czech Republic.
Herring WL, Herrmann JW. Threshold-based heuristics for the single-day surgery scheduling problem. Presented at the Annual Meeting of the Institute for Operations Research and Management Science; November 2010. Austin, TX.
Davis AE, Ladner D, Friedewald J. Analysis of kidney transplant center locations in the United States. Poster presented at the American Society of Nephrologists; November 2010. Previously presented at the American Transplant Congress.
Davis AE, Mehrotra S, Daskin MS. Distribution robust newsvendor models for shift nurse demand estimation. Poster presented at the Annual Meeting of the Institute for Operations Research and Management Science; November 2010.
Jensen MS, Rebordosa C, Thulstrup AM, Toft G, Sørensen HT, Bonde JP. Maternal use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy and risk of cryptorchidism. Epidemiology. 2010 Nov;21(6):779-85.
Layton JB, Hogan SL, Jennette CE, Kenderes B, Krisher J, Jennette JC, McClellan WM. Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases. Clin J Am Soc Nephrol. 2010 Nov;5(11):2046-52. doi: 10.2215/CJN.03550410.
Barnett C, Muckstadt JA. Using simulation to assess public health emergency distribution networks: the emergency supply chain operations evaluator (ESCOE). Presented at the INFORMS Annual Meeting 2010; November 2010. Austin, TX.
Fehnel S, Ervin CM, Lewis B, Carson RT, Johnston JM. Identifying endpoints for irritable bowel syndrome (IBS) clinical trials: incorporating the patient's voice. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. [abstract] Value Health. 2010 Nov; 13(7):A372.
Stull DE, van Hanswijck de Jonge P, Houghton KF, Kocun C, Sandor DW. Development of the US national frequent heartburn index (HBI) and associated composite score. Presented at the 17th Annual Conference of the International Society for Quality of Life Research; October 27, 2010. London, England.
Sturmer T, Rothman KJ, Avorn J, Glynn RJ. Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution—A simulation study. Am J Epidemiol. 2010 Oct 17;172(7):843-54.
Gramling R, Lash TL, Rothman KJ, Cabral HJ, Silliman R, Roberts M, Stefanick ML, Harrigan R, Bertoia ML, Eaton CB. Family history of later-onset breast cancer, breast healthy behavior and invasive breast cancer among postmenopausal women: a cohort study. Breast Cancer Res. 2010 Oct 12;12(5):R82.
Amonkar MM, Sherrill B, Zhou X. A review of the impact of lapatinib on health-related quality of life of patients with newly diagnosed and refractory metastatic breast cancer. Poster presented at the 2010 Breast Cancer Symposium; October 4, 2010. National Harbor, MD.